Journal of Clinical Medicine (Oct 2023)

The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective

  • Martina Nesti,
  • Vincenzo Russo,
  • Zefferino Palamà,
  • Luca Panchetti,
  • Silvia Garibaldi,
  • Umberto Startari,
  • Gianluca Mirizzi,
  • Marcello Piacenti,
  • Andrea Rossi,
  • Luigi Sciarra

DOI
https://doi.org/10.3390/jcm12206675
Journal volume & issue
Vol. 12, no. 20
p. 6675

Abstract

Read online

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a new technology for the management of ICD patients. But what is the patients’ perspective? Previous studies on the transvenous ICD (TV-ICD) showed that device implantation is related not only to anxiety and depression because of the fear of ICD shocks, but also to many biopsychosocial factors like body image changes, perceived reduction of socialization and limitation in professional and sports activities. Anxiety and distress are more evident in younger women because of aesthetic reasons. The scar size and the position of the S-ICD can help these patients and positively influence their social relationships. Moreover, the position of the S-ICD reduces possible complications from catheters due to stress injury and can improve patients’ professional life by avoiding some work activity limitations. An S-ICD can be also a good option for athletes in avoiding subclavian crash and reducing inappropriate shocks. However, some questions remain unsolved because an S-ICD is not suitable for patients with indications for pacing, cardiac resynchronization therapy or anti-tachycardia pacing. In conclusion, the use of an S-ICD can assist physicians in reducing the negative impact of implantation on the well-being of some groups of patients by helping them to avoid depression and anxiety as well as improving their noncompliance with their medical treatment.

Keywords